基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 GPM6A抗体 GPM6A抗体
  • GPM6A抗体
  • GPM6A抗体
  • GPM6A抗体

1/3

GPM6A抗体

Rabbit Polyclonal GPM6A Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-14

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
GPM6A抗体
英文名称:
Rabbit Polyclonal GPM6A Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3875 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
GPM6A

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesM6A; GPM6
WB Predicted band size31 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human GPM6A
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 20 μg, Lane: Human fetal brain tissue, Primary antibody: P07998(GPM6A Antibody) at dilution 1/1050, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 1 second    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human brain tissue using P07998(GPM6A Antibody) at dilution 1/50. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P07998(GPM6A Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于GPM6A抗体的3篇虚构参考文献示例(基于类似研究主题的合理推测,非真实文献):

---

1. **文献名称**: "Characterization of a novel polyclonal antibody for GPM6A in neuronal membrane localization studies"

**作者**: Smith J, et al.

**摘要**: 本研究开发了一种针对GPM6A C端表位的兔多克隆抗体,验证了其在Western blot和免疫组化中的特异性。实验表明,GPM6A主要定位于海马神经元膜上,并参与神经突触的可塑性调节。

2. **文献名称**: "GPM6A expression is reduced in schizophrenia: Evidence from postmortem brain analysis using a validated antibody"

**作者**: Lee H, et al.

**摘要**: 通过使用特异性抗体验证,作者发现精神分裂症患者前额叶皮质中GPM6A蛋白表达显著降低。该抗体经敲除小鼠模型验证无交叉反应,支持GPM6A在精神疾病中的潜在病理作用。

3. **文献名称**: "GPM6A interacts with the mTOR signaling pathway: Insights from co-immunoprecipitation assays"

**作者**: Garcia R, et al.

**摘要**: 利用GPM6A特异性抗体进行免疫共沉淀实验,揭示了GPM6A与mTOR通路蛋白的相互作用,提示其可能通过调控神经元内合成代谢参与神经退行性疾病。

---

注:以上文献为模拟内容,实际文献需通过PubMed/Google Scholar等平台检索确认。

       

背景信息

The GPM6A antibody targets the glycoprotein M6A (GPM6A), a member of the proteolipid protein family (PLP/PLP/DM20) predominantly expressed in the central nervous system. GPM6A is a transmembrane protein involved in neuronal differentiation, synaptic plasticity, and regulation of neurotransmitter release. It shares structural homology with myelin proteolipid proteins and is thought to participate in membrane organization, neurite outgrowth, and cholesterol homeostasis. Dysregulation of GPM6A has been implicated in neuropsychiatric disorders, including depression, schizophrenia, and autism spectrum disorders, highlighting its potential role in neural circuit development and function.

Antibodies against GPM6A are widely used in neuroscience research to study its expression patterns, subcellular localization, and interactions. They enable detection via techniques such as Western blotting, immunohistochemistry, and immunofluorescence. Commercially available GPM6A antibodies are typically raised in hosts like rabbits or mice, using immunogenic peptides derived from conserved regions of the human or rodent protein. Validation often includes knockout cell lines or tissue controls to confirm specificity. Recent studies have leveraged these antibodies to explore GPM6A's involvement in stress response, axonal guidance, and its interaction with synaptic proteins like neuroligins. However, variability in antibody performance across species or experimental conditions necessitates careful optimization.

       
GPM6A抗体;GPM6A;GPM6A Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

GPM6A抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价